E. Eisenhauer
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 18
- Lung Cancer Research Studies 8
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations 5
- Hepatology top 0.2%
- Cancer Research top 0.2%
- Cancer, Lipids, and Metabolism 6
-
- Ovarian cancer diagnosis and treatment 14
-
- Cancer therapeutics and mechanisms 6
-
- Statistical Methods in Clinical Trials 4
-
- Chemotherapy-related skin toxicity 4
E. Eisenhauer
61 papers receiving 22.4k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 11.9k
- Pulmonary and Respiratory Medicine 9.8k
- Hepatology 2.1k
- Cancer Research 3.7k
- Radiology, Nuclear Medicine and Imaging 4.3k
Countries citing papers authored by E. Eisenhauer
This map shows the geographic impact of E. Eisenhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Eisenhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Eisenhauer more than expected).
Fields of papers citing papers by E. Eisenhauer
This network shows the impact of papers produced by E. Eisenhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Eisenhauer. The network helps show where E. Eisenhauer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Eisenhauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 9 | |
| 2 | 2006 | 335 | |
| 3 | 2006 | 21 | |
| 4 | 1999 | 29 | |
| 5 | 1996 | 45 | |
| 6 | 1996 | 81 | |
| 7 | 1996 | 15 | |
| 8 | 1994 | 123 | |
| 9 | 1994 | 7 | |
| 10 | 1994 | 17 | |
| 11 | 1994 | 27 | |
| 12 | 1993 | 7 | |
| 13 | 1993 | 11 | |
| 14 | 1993 | 4 | |
| 15 | 1993 | 26 | |
| 16 | 1992 | 10 | |
| 17 | 1991 | 5 | |
| 18 | 1990 | 26 | |
| 19 | 1990 | 35 | |
| 20 | Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study. | 1986 | 28 |
About E. Eisenhauer
E. Eisenhauer is a scholar working on Reproductive Medicine, Oncology and Cancer Research, having authored 62 papers that have together received 22.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (18 papers), Ovarian cancer diagnosis and treatment (14 papers), Lung Cancer Research Studies (8 papers), Cancer therapeutics and mechanisms (6 papers), Cancer, Lipids, and Metabolism (6 papers), Lung Cancer Treatments and Mutations (5 papers), Statistical Methods in Clinical Trials (4 papers) and Chemotherapy-related skin toxicity (4 papers). The work is most often cited by research in Oncology (11.9k citations), Pulmonary and Respiratory Medicine (9.8k citations) and Hepatology (2.1k citations). E. Eisenhauer has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include P. Therasse, Lalitha Shankar, Stephen J. Gwyther, Jan Bogaerts, Janet Dancey, Richard Kaplan, Daniel J. Sargent, Lori E. Dodd, Lawrence H. Schwartz and Larry Rubinstein. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, International Journal of Gynecological Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.